Article Detail - JE Part B
Billing and Coding: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (A59179) Final Billing and Coding Article - Effective August 06, 2023
This Local Coverage Determination (LCD) has completed the Open Public Meeting and is now finalized under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Medicare Coverage Database (MCD) Number/Contractor Determination Number: A59179
Billing and Coding Article Title: Billing and Coding: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
Effective Date: August 06, 2023
Summary of Billing and Coding Article: The information in this article contains billing, coding or other guidelines that complement the Local Coverage Determination (LCD) for MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma.
Visit the Proposed LCDs webpage to access this Billing and Coding Article.